Ovarian cancer is frequently called a silent killer, but that description is not entirely accurate. Most women with ovarian cancer do experience symptoms. The real problem is that those symptoms are easy to dismiss and often not recognised as warning signs of cancer until the disease has already reached an advanced stage. This article explains what ovarian cancer symptoms actually look like, why they are missed so often, who is most at risk, and when a symptom that seems ordinary deserves urgent investigation. For related reading, see our articles on multi-cancer early detection blood tests and what survivorship care looks like once cancer is in remission.

Key Takeaways

  • Ovarian cancer is the most lethal gynaecological cancer, largely because approximately 70% of cases are diagnosed at an advanced stage.
  • The most common symptoms include persistent bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency.
  • These symptoms are easy to mistake for digestive, urinary, or musculoskeletal conditions, which is why diagnosis is frequently delayed.
  • Back pain, particularly in the lower back, is a commonly overlooked ovarian cancer symptom when it appears alongside other pelvic complaints.
  • The key clinical signal is persistence and change from baseline: symptoms that are new, occur more than 12 days per month, and do not resolve with simple treatment warrant medical evaluation.
  • BRCA1 and BRCA2 gene mutations, family history, and age are the strongest risk factors for ovarian cancer.

What Is Ovarian Cancer and Why Is It So Frequently Diagnosed Late?

Ovarian cancer is a malignancy that originates in the ovaries, the fallopian tubes, or the peritoneum. The most common type is epithelial ovarian cancer, which accounts for roughly 90% of cases. The ovaries sit deep in the pelvis, and a tumour can grow to a considerable size before causing noticeable symptoms. There is also no reliable, widely available screening test for the general population, unlike cervical cancer, which has the Pap smear. According to the American Cancer Society, the five-year survival rate for ovarian cancer diagnosed at a localised stage is over 90%. When diagnosed at a distant stage, it falls to approximately 31%. This survival gap makes earlier recognition of symptoms clinically critical.

For context on when to begin cancer screening, see our age-wise guide: When Should You Start Cancer Screening?

What Are the Symptoms of Ovarian Cancer?

The four symptoms most consistently identified in ovarian cancer patients across large studies are:

  • Bloating: A feeling of abdominal fullness, distension, or swelling that does not resolve after bowel movements and is not clearly tied to specific foods.
  • Pelvic or abdominal pain: Pressure, cramping, or aching in the lower abdomen or pelvis that is persistent rather than cyclic.
  • Difficulty eating or feeling full quickly: A reduced appetite or a sensation of fullness after eating much less than usual (early satiety).
  • Urinary symptoms: Urgency (a sudden need to urinate) or frequency (needing to urinate more often than usual) that is new and not explained by infection.

Additional symptoms that are commonly reported but receive less attention include:

  • Lower back pain: Dull, persistent aching in the lower back or sides that has no clear musculoskeletal cause and does not improve with rest or over-the-counter pain relief.
  • Constipation or other changes in bowel habits that are unexplained and persistent
  • Pain during sexual intercourse (dyspareunia)
  • Unexplained fatigue that does not improve with rest
  • Irregular or postmenopausal vaginal bleeding
  • Unintentional weight loss or weight gain from ascites (fluid in the abdomen)

Why Are Bloating and Back Pain So Often Missed as Ovarian Cancer Symptoms?

Bloating is one of the most common complaints in any general practice setting. It is a cardinal feature of irritable bowel syndrome, a common side effect of dietary choices, and a frequent premenstrual symptom. Back pain is even more commonly attributed to musculoskeletal causes or disc problems.

Research published in the British Journal of General Practice found that women with ovarian cancer visit their GP an average of three times before the correct diagnosis is made. The clinical lesson is that bloating or back pain that is new, persistent, occurs frequently (more than 12 days per month), and does not resolve with standard treatment deserves pelvic assessment, not just symptomatic management.

Who Is at Highest Risk for Ovarian Cancer?

  • BRCA1 and BRCA2 gene mutations: Women with a BRCA1 mutation have a lifetime risk of approximately 40 to 46%. Women with a BRCA2 mutation have a lifetime risk of approximately 10 to 27%.
  • Family history of ovarian, breast, or colorectal cancer: A family history of ovarian cancer in a first-degree relative roughly triples lifetime risk.
  • Age: Ovarian cancer is most commonly diagnosed in women aged 55 and older. The median age at diagnosis is approximately 63.
  • Endometriosis: Women with endometriosis have a modestly elevated risk of certain ovarian cancer subtypes.
  • No history of pregnancy or late first pregnancy: Women who have never been pregnant or who had their first child after age 35 have a slightly elevated risk.
  • Hormone replacement therapy (HRT): Long-term use of combined oestrogen-progestogen HRT is associated with a modest increase in risk.

Obesity: Excess body weight significantly increases ovarian cancer risk. See our full article on how obesity increases cancer risk for the broader picture.

What Are the Early Signs of Ovarian Cancer to Watch For?

  • Bloating that is new, persistent, and present on most days of the month
  • A feeling of pressure or heaviness in the pelvis that is new and does not resolve
  • Needing to urinate more often or more urgently without a urinary infection being present
  • Eating less than usual because of fullness or discomfort, without a clear dietary reason
  • Lower back pain that is persistent, not clearly mechanical, and has appeared alongside any of the above
  • Any new symptom that occurs more than 12 days per month and represents a change from normal

How Is Ovarian Cancer Diagnosed and Staged?

Diagnosing ovarian cancer involves a combination of clinical examination, blood tests, and imaging. For a broader look at how blood-based testing is evolving in oncology, see our article on liquid biopsy and cancer detection.

  • Pelvic examination: A bimanual pelvic exam can detect ovarian enlargement or irregularity.
  • Transvaginal ultrasound (TVUS): The primary imaging modality for evaluating the ovaries. Can detect ovarian masses and identify ascites.
  • CA-125 blood test: A tumour marker elevated in many epithelial ovarian cancers. Not sufficiently sensitive or specific to be used alone for diagnosis.
  • CT scan of the abdomen and pelvis: Used for staging to assess whether the cancer has spread to lymph nodes or other abdominal organs.
  • MRI: Provides detailed characterisation of pelvic masses when ultrasound findings are equivocal.
  • BRCA and genetic testing: Recommended for all women newly diagnosed with epithelial ovarian cancer, as results affect both treatment decisions and family risk assessment.
  • Surgical staging: Definitive diagnosis and staging require surgery and tissue biopsy.

How Is Ovarian Cancer Treated?

Treatment depends on the stage at diagnosis, the histological subtype, and the patient’s genetic profile. For an overview of how targeted therapies and immunotherapy work in cancer treatment, see our article on targeted therapy versus chemotherapy.

  • Surgery (cytoreduction or debulking): The cornerstone of ovarian cancer treatment. The goal is to remove as much tumour as possible.
  • Platinum-based chemotherapy: The standard first-line regimen is carboplatin combined with paclitaxel.
  • PARP inhibitors: For women with BRCA1 or BRCA2 mutations, PARP inhibitors (olaparib, niraparib, rucaparib) are used as maintenance therapy.
  • Bevacizumab: An anti-angiogenic drug added to chemotherapy and used as maintenance therapy in certain advanced ovarian cancer cases.
  • Immunotherapy: Currently being studied in clinical trials; not yet a standard first-line treatment.

Is This the Right Concern for You?

If you or a loved one has been experiencing persistent bloating, pelvic pain, back pain, or urinary changes that are new and do not resolve, a pelvic assessment is warranted. Consult Dr. Namratha Sai Reddy’s clinic if you or a loved one is experiencing:

  • Persistent bloating, pelvic discomfort, or early satiety occurring on most days
  • Lower back pain with no clear musculoskeletal cause, particularly alongside pelvic symptoms
  • A known BRCA mutation or significant family history of ovarian or breast cancer
  • Abnormal pelvic ultrasound findings or elevated CA-125 requiring specialist interpretation
  • Postmenopausal vaginal bleeding or new urinary symptoms without infection

When Should Women Seek Urgent Medical Care?

  • Sudden, severe abdominal or pelvic pain (possible ovarian torsion or rupture)
  • Rapid and severe abdominal distension with difficulty breathing
  • Heavy or uncontrolled vaginal bleeding
  • Fever with abdominal pain and tenderness
  • Inability to eat, drink, or keep fluids down
  • New neurological symptoms or sudden deterioration in overall condition during treatment

If any of these occur, go to the nearest emergency department or call emergency services immediately.

Medical References

Frequently Asked Questions

1. What are the early symptoms of ovarian cancer?

The earliest symptoms include persistent bloating, pelvic or abdominal pain, feeling full quickly, and urinary urgency or frequency. These symptoms are often subtle and easy to attribute to other causes.

2. Why is ovarian cancer called a silent killer?

Because its early symptoms closely mimic common, benign conditions like irritable bowel syndrome or bladder infections, most cases are not diagnosed until the cancer has spread beyond the ovary.

3. Can back pain be a sign of ovarian cancer?

Yes. Lower back pain, particularly when it is persistent, has no clear musculoskeletal explanation, and occurs alongside other pelvic or abdominal symptoms, can be a sign of ovarian cancer that is frequently overlooked.

4. What does ovarian cancer bloating feel like?

Ovarian cancer bloating tends to be persistent and present on most days. It does not resolve after bowel movements and is not clearly tied to specific foods. It may be accompanied by visible abdominal distension or a feeling of pressure.

5. How is ovarian cancer diagnosed?

Diagnosis involves a pelvic examination, transvaginal ultrasound, CA-125 blood test, and CT scan for staging. Definitive diagnosis requires surgical biopsy and pathological examination of removed tissue.

6. What is CA-125 and is it a reliable test for ovarian cancer?

CA-125 is a blood tumour marker that is elevated in many ovarian cancers but can also be raised by benign conditions. It is not reliable enough to diagnose ovarian cancer on its own but is useful for monitoring treatment response.

7. Who should be tested for BRCA mutations?

Women with a personal or family history of ovarian cancer, breast cancer (particularly at a young age or bilateral), fallopian tube cancer, or Ashkenazi Jewish ancestry should discuss BRCA genetic testing with their doctor.

8. Is ovarian cancer hereditary?

Approximately 15 to 20% of ovarian cancer cases are linked to inherited gene mutations, most commonly BRCA1 and BRCA2. The majority of cases are sporadic.

9. What is the survival rate for ovarian cancer?

Survival rates vary significantly by stage. When detected at a localised stage, the five-year survival rate exceeds 90%. For advanced-stage disease that has spread to distant organs, it is approximately 31%.

10. What should I do if I have persistent bloating and back pain?

If bloating, pelvic pain, back pain, or urinary symptoms are new, occur on most days, and have persisted for more than two to three weeks without a clear explanation, see your doctor for a pelvic assessment.

This article is for informational purposes and does not replace professional medical advice. Always consult your oncologist before making decisions about your diagnosis or treatment plan.